Disclosure Of Entity's Operating Segments [Text Block]

Captor Therapeutics S.A. - Filing #6179999

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	—	15	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	9 158 PLN	—	—	—	3 986 PLN	—
Profit (loss) before tax	—	—	35 894 PLN	—	—	—	32 572 PLN	—
Profit (loss) from continuing operations	—	—	35 894 PLN	—	—	—	32 572 PLN	—
Profit (loss)	—	35 894 PLN	35 894 PLN	35 894 PLN	—	32 572 PLN	32 572 PLN	32 572 PLN
Assets	113 000 PLN	—	—	—	143 541 PLN	—	—	—
Liabilities	16 678 PLN	—	—	—	19 340 PLN	—	—	—
Cash flows from (used in) operating activities	—	—	22 948 PLN	—	—	—	28 473 PLN	—
Cash flows from (used in) investing activities	—	—	17 630 PLN	—	—	—	5 113 PLN	—
Cash flows from (used in) financing activities	—	—	6 329 PLN	—	—	—	140 875 PLN	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]